B/D HPP
Human Liver Proteome Project (HLPP)
GET INVOLVED: Get in touch at office@hupo.org to learn more
Mission & Goals
The liver is a central organ in human body that controls metabolic homeostasis, provide essential substances to the organism and allow detoxification of xenobiotics. In addition to its biological function, liver physiology is peculiar in different aspects, including its regeneration capacity. Despite the intense research performed during the last couple of decades, there are still many open questions in regard of the molecular mechanisms underlying liver function and, most importantly, liver disease. This constraint largely restricts the development of more efficient diagnostic and therapeutic strategies for the better management of the patients. In the postgenomic era, the Human Liver Initiative started in 2002 as a large-scale international collaborative initiative aiming to define a comprehensive and dynamic map of the human liver proteome.
HLPP Membership
For more information or participation opportunities please contact us.
Leadership Information
Chair:
Daniel Martins-de-Souza, Ph.D
University of Campinas, Sao Paulo, Brazil
Chair:
Melanie Föcking, Ph.D
Royal College of Surgeons, Dublin, Ireland
Executive Committee Members:
Katrin Marcus, Ph.D Ruhr University, Bochum, Germany
Oliver Schubert, MD, Ph.D University of Adelaide, Adelaide, Australia
Peter Nilsson, Ph.D KTH – Royal Institute of Technology, Stockholm, Sweden
Robert Mccullumsmit, MD, Ph.D University of Toledo, Toledo, USA
Current Lines of Work
- Definition of liver proteome by characterization of all specific liver cell types and their interaction in health and disease.
- Definition of priority protein lists relevant in liver physiology and participating in the molecular pathogenesis of liver disorders. Example: panel of 15 enzymes of One Carbon Metabolism.
- To develop targeted standardized methods for the quantification of clinically relevant proteins. Example: SRM assay for a panel of 12 enzymes of One Carbon Metabolism.
- In depth dynamic characterization of liver regeneration by a combination of proteomics and phosphoproteomics.
- To identify novel proteins relevant in liver biology and pathology by means of proteogenomics.
- Identify differentially expressed proteins in Hepatocellular carcinoma (HCC) patients who underwent liver transplantaion, using proteomics of vascular invation, well differentiated, moderate differentiated, and poor differentiated liver biopsies
- Non Alcoholic Fatty Liver Disease (NAFLD) molecular characterization and early marker discovery.
- Analysis of molecular mechanisms in drug induced liver injury.
- To study the role of ubiquitin-like proteins in liver disease.
Publications:
Liver cancer-associated changes to the proteome: what deserves clinical focus?
- Mato JM, Elortza F, Lu SC, Brun V, Paradela A, Corrales FJ. Expert Rev Proteomics. 2018 Sep;15(9):749-756. doi: 10.1080/14789450.2018.1521277. Epub 2018 Sep 19. PMID:30204005
Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria
- Serrano-Mendioroz I, Sampedro A, Serna N, de Salamanca RE, Sanz-Parra A, Corrales F, Berraondo P, Millet O, Fontanellas A. Hum Mol Genet. 2018 Nov 1;27(21):3688-3696. doi: 10.1093/hmg/ddy283. PMID:30085095
Abundance of Cytochromes in Hepatic Extracellular Vesicles Is Altered by Drugs Related With Drug-Induced Liver Injury
- Palomo L, Mleczko JE, Azkargorta M, Conde-Vancells J, González E, Elortza F, Royo F, Falcon-Perez JM. Hepatol Commun. 2018 Aug 23;2(9):1064-1079. doi: 10.1002/hep4.1210. eCollection 2018 Sep. PMID:30202821
SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
- Zubiete-Franco I, García-Rodríguez JL, Lopitz-Otsoa F, Serrano-Macia M, Simon J, Fernández-Tussy P, Barbier-Torres L, Fernández-Ramos D, Gutiérrez-de-Juan V, López de Davalillo S, Carlevaris O, Beguiristain Gómez A, Villa E, Calvisi D, Martín C, Berra E, Aspichueta P, Beraza N, Varela-Rey M, Ávila M, Rodríguez MS, Mato JM, Díaz-Moreno I, Díaz-Quintana A, Delgado TC, Martínez-Chantar ML. EBioMedicine. 2018 Dec 26. pii: S2352-3964(18)30608-X. doi: 10.1016/j.ebiom.2018.12.031. [Epub ahead of print] PMID:30594553
Prohibitin 1 Acts As a Negative Regulator of Wingless/Integrated-Beta-Catenin Signaling in Murine Liver and Human Liver Cancer Cells
- Mavila N, Tang Y, Berlind J, Ramani K, Wang J, Mato JM, Lu SC. Hepatol Commun. 2018 Sep 27;2(12):1583-1600. doi: 10.1002/hep4.1257. eCollection 2018 Dec.PMID:30556043
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr-/-Leiden Mice
- Morrison MC, Verschuren L, Salic K, Verheij J, Menke A, Wielinga PY, Iruarrizaga-Lejarreta M, Gole L, Yu WM, Turner S, Caspers MPM, Martínez-Arranz I, Pieterman E, Stoop R, van Koppen A, van den Hoek AM, Mato JM, Hanemaaijer R, Alonso C, Kleemann R. Hepatol Commun. 2018 Oct 29;2(12):1513-1532. doi: 10.1002/hep4.1270. eCollection 2018 Dec. PMID:30556039
The mitochondrial chaperone Prohibitin 1 negatively regulates interleukin-8 in human liver cancers
- Yang JW, Murray B, Barbier-Torres L, Liu T, Liu Z, Yang H, Fan W, Wang J, Li Y, Seki E, Mato JM, Lu SC. J Biol Chem. 2018 Dec 6. pii: jbc.RA118.004863. doi: 10.1074/jbc.RA118.004863. [Epub ahead of print] PMID:30523154
MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
- Fernández-Ramos D, Fernández-Tussy P, Lopitz-Otsoa F, Gutiérrez-de-Juan V, Navasa N, Barbier-Torres L, Zubiete-Franco I, Simón J, Fernández AF, Arbelaiz A, Aransay AM, Lavín JL, Beraza N, Perugorria MJ, Banales JM, Villa E, Fraga MF, Anguita J, Avila MA, Berasain C, Iruzibieta P, Crespo J, Lu SC, Varela-Rey M, Mato JM, Delgado TC, Martínez-Chantar ML. Cell Death Dis. 2018 Sep 20;9(10):958. doi: 10.1038/s41419-018-1014-y. PMID:30237481
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
- Urquiza P, Laín A, Sanz-Parra A, Moreno J, Bernardo-Seisdedos G, Dubus P, González E, Gutiérrez-de-Juan V, García S, Eraña H, San Juan I, Macías I, Ben Bdira F, Pluta P, Ortega G, Oyarzábal J, González-Muñiz R, Rodríguez-Cuesta J, Anguita J, Díez E, Blouin JM, de Verneuil H, Mato JM, Richard E, Falcón-Pérez JM, Castilla J, Millet O. Sci Transl Med. 2018 Sep 19;10(459). pii: eaat7467. doi: 10.1126/scitranslmed.aat7467. PMID:30232228
Fine-tuning of SIRT1 expression is essential to protect the liver from cholestatic liver disease
- Blokker BA, Maijo M, Echeandia M, Galduroz M, Patterson AM, Ten A, Philo M, Schungel R, Gutierrez-de Juan V, Halilbasic E, Fuchs C, Le Gall G, Milkiewicz M, Milkiewicz P, Banales JM, Rushbrook SM, Mato JM, Trauner M, Müller M, Martínez-Chantar ML, Varela-Rey M, Beraza N. Hepatology. 2018 Sep 19. doi: 10.1002/hep.30275. [Epub ahead of print] PMID:30229970
Liver cancer-associated changes to the proteome: what deserves clinical focus?
- Mato JM, Elortza F, Lu SC, Brun V, Paradela A, Corrales FJ. Expert Rev Proteomics. 2018 Sep;15(9):749-756. doi: 10.1080/14789450.2018.1521277. Epub 2018 Sep 19. PMID:30204005
Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
- Mayo R, Crespo J, Martínez-Arranz I, Banales JM, Arias M, Mincholé I, Aller de la Fuente R, Jimenez-Agüero R, Alonso C, de Luis DA, Vitek L, Stritesky J, Caballería J, Romero-Gómez M, Martín-Duce A, Mugüerza Huguet JM, Busteros-Moraza JI, Idowu MO, Castro A, Martínez-Chantar ML, Ortiz P, Bruha R, Lu SC, Bedossa P, Noureddin M, Sanyal AJ, Mato JM. Hepatol Commun. 2018 May 4;2(7):807-820. doi: 10.1002/hep4.1188. eCollection 2018 Jul. PMID:30027139
Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer
- Liu T, Yang H, Fan W, Tu J, Li TWH, Wang J, Shen H, Yang J, Xiong T, Steggerda J, Liu Z, Noureddin M, Maldonado SS, Annamalai A, Seki E, Mato JM, Lu SC. Gastroenterology. 2018 Aug;155(2):557-571.e14. doi: 10.1053/j.gastro.2018.04.032. Epub 2018 May 5. PMID:29733835
Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
- Bril F, Millán L, Kalavalapalli S, McPhaul MJ, Caulfield MP, Martinez-Arranz I, Alonso C, Ortiz Betes P, Mato JM, Cusi K. Diabetes Obes Metab. 2018 Jul;20(7):1702-1709. doi: 10.1111/dom.13285. Epub 2018 Apr 14. PMID:29527789
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
- Mölleken C, Ahrens M, Schlosser A, Dietz J, Eisenacher M, Meyer HE, Schmiegel W, Holmskov U, Sarrazin C, Sorensen GL, Sitek B, Bracht T. Clin Mol Hepatol. 2018 Nov 19. doi: 10.3350/cmh.2018.0029. [Epub ahead of print] PMID:30449076
Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours
- Nwosu ZC, Battello N, Rothley M, Piorońska W, Sitek B, Ebert MP, Hofmann U, Sleeman J, Wölfl S, Meyer C, Megger DA, Dooley S. J Exp Clin Cancer Res. 2018 Sep 3;37(1):211. doi: 10.1186/s13046-018-0872-6. Erratum in: J Exp Clin Cancer Res. 2018 Nov 2;37(1):267. PMID:30176945
A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy
- Manceau V, Palard X, Rolland Y, Pracht M, Le Sourd S, Laffont S, Boudjema K, Lievre A, Mesbah H, Haumont LA, Lenoir L, Brun V, Uguen T, Edeline J, Garin E. Eur J Nucl Med Mol Imaging. 2018 Sep;45(10):1731-1741. doi: 10.1007/s00259-018-3990-7. Epub 2018 Mar 20. PMID:29560519
Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates
- Weiß F, Hammer HS, Klein K, Planatscher H, Zanger UM, Norén A, Wegler C, Artursson P, Joos TO, Poetz O. Drug Metab Dispos. 2018 Apr;46(4):387-396. doi: 10.1124/dmd.117.078626. Epub 2018 Jan 17. PMID:29343608
Mixture effects of two plant protection products in liver cell lines
- Zahn E, Wolfrum J, Knebel C, Heise T, Weiß F, Poetz O, Marx-Stoelting P, Rieke S. Food Chem Toxicol. 2018 Feb;112:299-309. doi: 10.1016/j.fct.2017.12.067. Epub 2017 Dec 30. PMID:29294346
Targeting Endothelial Erk1/2-Akt Axis as a Regeneration Strategy to Bypass Fibrosis during Chronic Liver Injury in Mice
- Lao Y, Li Y, Zhang P, Shao Q, Lin W, Qiu B, Lv Y, Tang L, Su S, Zhang H, Tian C, Sun A, Wei H, Zhang P, Wu Y, Jiang Y, He F. Mol Ther. 2018 Dec 5;26(12):2779-2797. doi: 10.1016/j.ymthe.2018.08.016. Epub 2018 Aug 24. PMID:30266653
ER-associated ubiquitin ligase HRD1 programs liver metabolism by targeting multiple metabolic enzymes
- Wei J, Yuan Y, Chen L, Xu Y, Zhang Y, Wang Y, Yang Y, Peek CB, Diebold L, Yang Y, Gao B, Jin C, Melo-Cardenas J, Chandel NS, Zhang DD, Pan H, Zhang K, Wang J, He F, Fang D. Nat Commun. 2018 Sep 10;9(1):3659. doi: 10.1038/s41467-018-06091-7. PMID:30201971
Artificial MicroRNA-Mediated Tgfbr2 and Pdgfrb Co-Silencing Ameliorates Carbon Tetrachloride-Induced Hepatic Fibrosis in Mice
- Jiang Y, Zhao Y, He F, Wang H. Hum Gene Ther. 2018 Nov 13. doi: 10.1089/hum.2018.047. [Epub ahead of print] PMID:30024280
Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels
- Cao P, Yang A, Wang R, Xia X, Zhai Y, Li Y, Yang F, Cui Y, Xie W, Liu Y, Liu T, Jia W, Jiang Z, Li Z, Han Y, Gao C, Song Q, Xie B, Zhang L, Zhang H, Zhang J, Shen X, Yuan Y, Yu F, Wang Y, Xu J, Ma Y, Mo Z, Yu W, He F, Zhou G. Gastroenterology. 2018 Aug;155(2):542-556. doi: 10.1053/j.gastro.2018.04.020. Epub 2018 Apr 24. PMID:29702115
A proteomics landscape of circadian clock in mouse liver
- Wang Y, Song L, Liu M, Ge R, Zhou Q, Liu W, Li R, Qie J, Zhen B, Wang Y, He F, Qin J, Ding C. Nat Commun. 2018 Apr 19;9(1):1553. doi: 10.1038/s41467-018-03898-2. PMID:29674717
Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
- Wang X, Dong Q, Li Q, Li Y, Zhao D, Sun J, Fu J, Meng F, Lin H, Luan J, Liu B, Wang M, Wang FS, He F, Tang L. Gastroenterology. 2018 Jun;154(8):2222-2236. doi: 10.1053/j.gastro.2018.03.021. Epub 2018 Mar 12. PMID:29544722